This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
$44.15
Share price
0.00%
Change (1 day)
118.89%
Change (1 year)
Categories
Albireo Pharma (ALBO) - Total assets
Total assets on the balance sheet as of September 2022 : $0.32 Billion USD
According to Albireo Pharma's latest financial reports the company's total assets are $0.32 Billion USD. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Albireo Pharma - Total assets on balance sheet (from 2005 to 2022)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2021-12-31 | $0.30 B | 5.76% |
| 2020-12-31 | $0.28 B | 73.02% |
| 2019-12-31 | $0.16 B | -11% |
| 2018-12-31 | $0.18 B | 153.29% |
| 2017-12-31 | $73.22 M | 47.45% |
| 2016-12-31 | $49.66 M | |
| 2016-09-30 | $28.86 M | -30.31% |
| 2015-09-30 | $41.42 M | 62.93% |
| 2014-09-30 | $25.42 M | -38.22% |
| 2013-09-30 | $41.15 M | 0.04% |
| 2012-09-30 | $41.13 M | -0.89% |
| 2011-09-30 | $41.5 M | 27.25% |
| 2010-09-30 | $32.61 M | -45.3% |
| 2009-09-30 | $59.62 M | -38.85% |
| 2008-09-30 | $97.51 M | 18.19% |
| 2007-09-30 | $82.5 M | 342.18% |
| 2006-09-30 | $18.65 M | 1461.42% |
| 2005-09-30 | $1.19 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.24 B | -24.40% | 🇺🇸 USA |